Skip to main content
Premium Trial:

Request an Annual Quote

Judy Lieberman, Patrice Courvalin

Premium
Cequent Pharmaceuticals announced that Harvard Medical School’s Judy Lieberman has joined its scientific advisory board.
 
Lieberman, well-known for her work in RNAi delivery, is a senior investigator at Harvard’s Immune Disease Institute.She holds a PhD in theoretical physics from Rockefeller Universityand an MD through the Harvard-Massachusetts Institute of Technology program in health, science, and technology.
 
Cequent also announced that Institut Pasteur professor Patrice Courvalin has also joined its SAB.
 
Courvalin is the head of the antibacterial agents unit at Institut Pasteur and holds a PhD in medical sciences from the University of Sciences in Paris.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.